Abnormal GF signalings can improve the survival through mediating RAS/RAF/MEK/ERK and PI3/AKT/mTOR pathways, and some GFs may boost tumor cell growth and metastasis by post-transcriptional mechanisms (202). This evidence concerns the gene AKT1 and neoplasm.